Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

PSTI

Pluristem Therapeutics (PSTI)

Pluristem Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PSTI
FechaHoraFuenteTítuloSímboloCompañía
09/06/202305:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PSTIPluristem Therapeutics Inc
01/06/202315:06Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PSTIPluristem Therapeutics Inc
09/05/202315:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PSTIPluristem Therapeutics Inc
25/04/202315:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
27/02/202306:58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PSTIPluristem Therapeutics Inc
27/02/202306:53Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PSTIPluristem Therapeutics Inc
16/02/202307:59Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PSTIPluristem Therapeutics Inc
16/02/202307:17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PSTIPluristem Therapeutics Inc
14/02/202305:27Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PSTIPluristem Therapeutics Inc
13/02/202315:39Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PSTIPluristem Therapeutics Inc
22/12/202207:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSTIPluristem Therapeutics Inc
21/09/202216:17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PSTIPluristem Therapeutics Inc
21/09/202215:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PSTIPluristem Therapeutics Inc
25/07/202206:00GlobeNewswire Inc.Pluri CEO Issues Shareholder UpdateNASDAQ:PSTIPluristem Therapeutics Inc
25/07/202200:00GlobeNewswire Inc.Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.” Reflecting the Company’s Strategy to Leverage its Innovative 3D Cell-based Technology Platform to Additional IndustriesNASDAQ:PSTIPluristem Therapeutics Inc
17/07/202207:20TipRanksPluristem (PSTI) Receives a Buy from H.C. WainwrightNASDAQ:PSTIPluristem Therapeutics Inc
13/07/202205:00GlobeNewswire Inc.Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture SurgeryNASDAQ:PSTIPluristem Therapeutics Inc
15/05/202207:25TipRanksDawson James Thinks Pluristem’s Stock is Going to RecoverNASDAQ:PSTIPluristem Therapeutics Inc
28/03/202202:00GlobeNewswire Inc.Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New PartnershipNASDAQ:PSTIPluristem Therapeutics Inc
23/03/202206:30GlobeNewswire Inc.Pluristem Releases PLX-R18 Hematology Phase I Study Results: Data Show Increase in All Blood Lines and Reduction in Blood TransfusionsNASDAQ:PSTIPluristem Therapeutics Inc
08/03/202206:12GlobeNewswire Inc.Pluristem and Tnuva Appoint Food Tech Veteran Eyal Rosenthal as Chief Executive Officer of their New Joint VentureNASDAQ:PSTIPluristem Therapeutics Inc
02/03/202206:00GlobeNewswire Inc.Pluristem CEO Issues Shareholder UpdateNASDAQ:PSTIPluristem Therapeutics Inc
24/02/202206:00GlobeNewswire Inc.Pluristem Announce the Closing of its Collaboration with Tnuva Group to Establish Cultured Food PlatformNASDAQ:PSTIPluristem Therapeutics Inc
10/01/202202:00GlobeNewswire Inc.Biotechnology Company Pluristem, and Israel’s Largest Food Producer Tnuva, Launch Landmark Collaboration to Establish Cultured Food PlatformNASDAQ:PSTIPluristem Therapeutics Inc
05/01/202203:11TipRanksDawson James Maintains a Buy Rating on Pluristem (PSTI)NASDAQ:PSTIPluristem Therapeutics Inc
27/12/202106:00GlobeNewswire Inc.Pluristem Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19NASDAQ:PSTIPluristem Therapeutics Inc
15/11/202106:10GlobeNewswire Inc.Pluristem Completes Enrollment of Its Multinational Phase III Study of Muscle Regeneration Following Hip Fracture SurgeryNASDAQ:PSTIPluristem Therapeutics Inc
10/11/202106:00GlobeNewswire Inc.Pluristem Receives Approval for Grant from the Israel Innovation Authority to Develop its Next-Generation CRISPR PLX PlatformNASDAQ:PSTIPluristem Therapeutics Inc
26/07/202115:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PSTIPluristem Therapeutics Inc
19/07/202106:00GlobeNewswire Inc.Pluristem Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of DirectorsNASDAQ:PSTIPluristem Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PSTI